AI summary
Summary of article:
Musk announces two Neuralink products
richest man in the worldmusk On the 30th, he posted an article on his social platform
Musk said Neuralink’s second product, called BlindSight, will allow people who are completely blind or congenitally blind to see again. He said that from the engineering and technical point of view, the product is ready and is only awaiting regulatory approval.
▼Source:
Foreign media reported that Neuralink’s blind-vision technology is designed to bypass damaged human eyes and optic nerves, and transmit visual information generated by cameras directly to the visual cortex of the brain.
The US Food and Drug Administration (FDA) has granted “Breakthrough Medical Device” status to BlindSight in September 2024 to expedite the regulatory review process, but this does not mean approval of its commercial use. The implanted device is still in the experimental stage, and Neuralink has not yet been proven to restore vision in human patients.
Musk had earlier also said that the name of Neuralink’s first product is Telepathy. This product allows humans to communicate with computers or other people at high speed simply by thinking.
He also emphasized that in the next few years its information output speed will far exceed the fastest human speaking or typing speed.
▼Video source:
Summary FAQ
-
BlindSight focuses on helping people who are completely blind, or even blind from birth, to restore vision by bypassing damaged eyes and optic nerves and sending image information directly to the visual cortex of the brain.
-
Musk said BlindSight is ready for engineering but still needs regulatory approval. Although the FDA has granted Breakthrough Medical Device status in September 2024, this does not mean it can be used commercially.
-
Telepathy is Neuralink’s first product, which aims to allow humans to communicate at high speed with computers or other people simply by thinking. Musk also said that in the future its output speed will be much faster than human speech or typing.
